Clinical Trials on SNS in India
Total 39 results
-
Tata Memorial CentreBhabha Atomic Research Centre (BARC)Active, not recruiting
-
Chaitanya Hospital, PuneUnknown
-
The Centre for Advanced Research & Development,...Unknown
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingIndia, Trinidad and Tobago
-
SanofiCompletedRelapsing Multiple SclerosisIndia
-
Immunic AGRecruitingMultiple SclerosisSpain, United States, India, Mexico, Bulgaria, Georgia, Lithuania, Moldova, Republic of, North Macedonia, Jordan, Greece, Albania, Colombia, Montenegro, Ukraine, Lebanon
-
SpineX Inc.Rancho Los Amigos National Rehabilitation Center, Downey, California, United... and other collaboratorsRecruitingStroke | Multiple Sclerosis | Neurogenic Bladder | Spinal Cord Injuries (Complete and Incomplete)United States, India, Canada
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Immunic AGRecruitingMultiple Sclerosis, Relapsing-RemittingTurkey, United States, India, United Kingdom, Bosnia and Herzegovina, Estonia, Poland, Romania, Serbia, Ukraine, Armenia, Peru
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
Experimental and Clinical Research Center, a cooperation...RecruitingMultiple Sclerosis | Demyelinating Diseases | Optic Neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseItaly, United States, Argentina, Australia, Botswana, Brazil, Colombia, Denmark, France, Germany, India, Israel, Japan, Korea, Republic of, Spain, United Kingdom, Zambia
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)United States, Belgium, Taiwan, Italy, Germany, Canada, Estonia, Mexico, Croatia, Slovakia, Turkey, India, Spain, Argentina, France, Israel, Australia, Austria, Serbia, Brazil, Guatemala, Latvia, Poland, Portugal, Russian Federation, Romania and more
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisLebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
-
Adamas Pharmaceuticals, Inc.CompletedMultiple Sclerosis | Walking ImpairmentUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple SclerosisUnited States, Korea, Republic of, India, Brazil, Poland, Canada, Bulgaria, United Kingdom, France, Greece, Italy, Russian Federation, Turkey, Mexico, Austria, Denmark, Guatemala
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, Canada, China, Spain, Italy, France, Slovenia, Japan, Turkey, Argentina, Estonia, Greece, Mexico, Poland, Sweden, Croatia, South Africa, Brazil, Slovakia, Bulgaria, Romania, India, Portugal, United Kingdom, Puerto Rico
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Australia, Canada, Mexico, Argentina, Puerto Rico, Chile
-
SanofiActive, not recruitingRelapsing Multiple SclerosisUnited States, Argentina, Belgium, Brazil, Canada, Chile, Croatia, Czechia, France, Germany, Greece, Hungary, India, Israel, Korea, Republic of, Latvia, Netherlands, Norway, Portugal, Puerto Rico, Russian Federation, Serbia, Slovakia, Spai... and more
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisBelgium, Italy, United States, Croatia, Spain, Netherlands, Switzerland, Thailand, Israel, Czechia, Estonia, Poland, France, Bulgaria, Russian Federation, Germany, Turkey, Slovakia, Australia, Denmark, Greece, Argentina, India, Hungary, United Kingdom and more
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, China, Spain, Switzerland, Italy, Belgium, Latvia, Poland, Argentina, India, Croatia, Bulgaria, Malaysia, Slovakia, Lebanon, Guatemala, Netherlands, Colombia, Chile, United Kingdom, Denmark, Hong Kong, Ireland
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...EMD Serono Research & Development Institute, Inc.Active, not recruitingRelapsing Multiple SclerosisUnited States, Belarus, Brazil, Bulgaria, Canada, France, Germany, Greece, India, Italy, Latvia, Lithuania, Malaysia, Moldova, Republic of, Norway, Philippines, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Saudi Arabia and more
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...EMD Serono Research & Development Institute, Inc.Active, not recruitingRelapsing Multiple SclerosisUnited States, Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Colombia, Croatia, Czechia, Estonia, Finland, France, Georgia, Germany, Hong Kong, Hungary, India, Israel, Italy, Korea, Republic of, M... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Argentina, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Germany, Hungary, Poland, Portugal, Russian Federation, Slovakia, Spain, Denmark, France, Japan, Israel, Taiwan, Turkey, Czechia, Argentina, Estonia, United Kingdom, India, C... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
University of British ColumbiaUniversity of Oxford; BC Childrens Hospital Research InstituteRecruitingMicroscopic Polyangiitis | Polyarteritis Nodosa | Eosinophilic Granulomatosis With Polyangiitis | Takayasu Arteritis | Wegeners Granulomatosis (Granulomatosis With Polyangiitis) | Primary CNS Vasculitis | Unclassified VasculitisCanada, United States, Thailand, United Kingdom, Germany, India, Denmark
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more